Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01062958 · ClinicalTrials.gov registry record
A Retrospective Analysis of Neevo®/Neevo®DHA Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy
A clinical trial, sponsored by Pamlab.
- Completed
- Registry status
- 100
- Enrollment target
NCT01062958 is a clinical trial that has completed, run by Pamlab. The registered enrollment target is 100 participants.
The verdict
NCT01062958 has completed, sponsored by Pamlab.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This study is a multi-site, retrospective chart review to determine the effect of Neevo® or Neevo®DHA (with higher folate and B12) versus standard prenatal vitamins on hemoglobin (Hgb) levels in pregnant women throughout the course of pregnancy. Neevo® is a prescription medical food indicated for the dietary management of women under a doctor's care who face high risk pregnancies, older overactive bladder (OB) patients and patients unable to fully metabolize folic acid. Data will be collected from existing patient charts of subjects administered Neevo® or Neevo®DHA daily compared to subjects administered a prenatal vitamin daily.
Interventions
- OTHER Neevo® (a medical food)
- OTHER Prenatal vitamins (≤1mg folic acid, 27 - 35mg iron, and ≤12mcg vitamin B12)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-12 |
| Est. Completion | 2010-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01062958
The ClinicalTrials.gov registry entry for NCT01062958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pamlab, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neevo® (a medical food) is the first listed.
NCT01062958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01062958 about?
NCT01062958 is a clinical study titled "A Retrospective Analysis of Neevo®/Neevo®DHA Compared to a Standard Prenatal Vitamin in Anemia During Pregnancy". This study is a multi-site, retrospective chart review to determine the effect of Neevo® or Neevo®DHA (with higher folate and B12) versus standard prenatal vitamins on hemoglobin (Hgb) levels in pregnant women throughout the course of pregnancy. Neevo® is a prescription medical food indicated for th...
What is the current status of trial NCT01062958?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2009-12. Estimated completion is 2010-02.
What interventions are being tested in trial NCT01062958?
The interventions under investigation include: Neevo® (a medical food) (OTHER), Prenatal vitamins (≤1mg folic acid, 27 - 35mg iron, and ≤12mcg vitamin B12) (OTHER).
Who is sponsoring clinical trial NCT01062958?
This trial is sponsored by Pamlab, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.